Helicobacter pylori testing market under the spotlight
This article was originally published in Clinica
Since it was established as a cause of peptic ulcers in 1983, Helicobacter pylori has emerged as one of the most important discoveries in gastroenterology. The role of H pylori in gastritis, peptic ulcer and gastric cancer is now proven, but research currently under way into possible associations with cardiovascular disease and a number of other conditions could guarantee an enormous market for H pylori diagnostic tests and antimicrobial eradication therapy, says a new report from Clinica Reports.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.